MX343327B - Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa. - Google Patents

Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.

Info

Publication number
MX343327B
MX343327B MX2013009570A MX2013009570A MX343327B MX 343327 B MX343327 B MX 343327B MX 2013009570 A MX2013009570 A MX 2013009570A MX 2013009570 A MX2013009570 A MX 2013009570A MX 343327 B MX343327 B MX 343327B
Authority
MX
Mexico
Prior art keywords
tnfa
assays
present
autoantibodies
detecting autoantibodies
Prior art date
Application number
MX2013009570A
Other languages
English (en)
Other versions
MX2013009570A (es
Inventor
Singh Sharat
Long Wang Shui
Ohrmund Linda
Hauenstein Scott
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2013009570A publication Critical patent/MX2013009570A/es
Publication of MX343327B publication Critical patent/MX343327B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Abstract

La presente invención se refiere a ensayos para detectar y medir la presencia o nivel de autoanticuerpos contra terapéuticos de fármaco anti-TNFa en una muestra. La presente invención es útil para optimizar terapia y monitorear pacientes que reciban terapéuticos de fármaco anti-TNFa para detectar la presencia o nivel de autoanticuerpos contra el fármaco. La presente invención también proporciona métodos para seleccionar terapia, optimizar terapia y/o reducir toxicidad en sujetos que reciban fármacos anti-TNFa para el tratamiento de enfermedades o trastornos mediados por TNFa.
MX2013009570A 2011-02-17 2012-02-16 Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa. MX343327B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161444097P 2011-02-17 2011-02-17
US201161484594P 2011-05-10 2011-05-10
US201161496501P 2011-06-13 2011-06-13
PCT/US2012/025437 WO2012154253A1 (en) 2011-02-17 2012-02-16 ASSAYS FOR DETECTING AUTOANTIBODIES TO ANTI-TNFα DRUGS

Publications (2)

Publication Number Publication Date
MX2013009570A MX2013009570A (es) 2013-09-06
MX343327B true MX343327B (es) 2016-11-01

Family

ID=45809635

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013009570A MX343327B (es) 2011-02-17 2012-02-16 Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.

Country Status (17)

Country Link
US (1) US20140045276A1 (es)
EP (1) EP2676137B1 (es)
JP (1) JP6063398B2 (es)
KR (1) KR20140008397A (es)
CN (1) CN103502815B (es)
AU (1) AU2012254150B2 (es)
BR (1) BR112013020981A2 (es)
CA (1) CA2827609A1 (es)
DK (1) DK2676137T3 (es)
ES (1) ES2530175T3 (es)
HK (1) HK1191688A1 (es)
IL (1) IL227853A (es)
MX (1) MX343327B (es)
RU (1) RU2013142278A (es)
SG (1) SG192770A1 (es)
WO (1) WO2012154253A1 (es)
ZA (1) ZA201306950B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010062960A2 (en) 2008-11-26 2010-06-03 Cedars-Sinai Medical Center METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
RU2571489C2 (ru) 2009-10-26 2015-12-20 Нестек С.А. Способы выявления препаратов и аутоантител против tnf
BR112013009376A2 (pt) 2010-10-18 2016-07-26 Nestec Sa métodos para determinar isótipos de anticorpos antifármacos
MX343324B (es) 2011-07-06 2016-11-01 Nestec Sa Ensayos para detectar auto anticuerpos neutralizadores de la terapia biologica con tnf alpha.
US10036745B2 (en) 2012-10-03 2018-07-31 Gyros Patent Ab Method and kit for analyte determination at acidic conditions
WO2014054013A1 (en) 2012-10-05 2014-04-10 Nestec S.A. Methods for predicting and monitoring mucosal healing
BR112015012482A2 (pt) * 2012-11-30 2017-07-11 Nestec Sa ensaios para detecção de autoanticorpos neutralizantes à terapia com produtos biológicos
WO2014122600A1 (en) 2013-02-05 2014-08-14 Nestec S.A. Methods of selecting combination therapy for colorectal cancer patients
CN105246501B (zh) 2013-03-27 2021-01-12 雪松-西奈医学中心 通过抑制tl1a的功能和相关信号传导途径来减轻并逆转纤维化和炎症
EP3022295A4 (en) 2013-07-19 2017-03-01 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
EP3077818B1 (en) 2013-12-03 2020-02-05 Prometheus Biosciences, Inc. Methods for predicting post-operative recurrence of crohn's disease
WO2015110989A1 (en) 2014-01-23 2015-07-30 Nestec S.A. Biomarker panel for assessment of mucosal healing
DK3105592T3 (en) 2014-02-11 2019-02-04 Genzyme Corp PROCEDURES FOR DETERMINING THE PRESENCE OR THE QUANTITY OF AN ANTI-MEDICINE ANTIBODY
JP6759104B2 (ja) 2014-04-04 2020-09-23 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 精密分子質量を用いた免疫グロブリンのアイソタイピング
CN104034896A (zh) * 2014-06-19 2014-09-10 华北制药集团新药研究开发有限责任公司 一种双抗体夹心elisa检测方法
EP3175242A4 (en) 2014-07-29 2017-12-27 Mayo Foundation for Medical Education and Research Quantifying monoclonal antibody therapeutics by lc-ms/ms
WO2016063204A1 (en) * 2014-10-20 2016-04-28 Nestec S.A. Methods for prediction of anti-tnf alpha drug levels and autoantibody formation
JP6739428B2 (ja) * 2014-11-05 2020-08-12 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ エフェクター機能抑制型ヒトまたはヒト化薬物抗体に対する抗薬物抗体の決定方法
BR112017011545A2 (pt) 2014-12-05 2018-03-13 Nestec Sa ensaio de desvio de mobilidade homogênea indireto para a detecção de produtos biológicos nas amostras do paciente
CN107110853A (zh) 2015-01-09 2017-08-29 阿通诺米斯公司 确定TNFα抑制药及其相应抗药抗体的量的通用测定法
WO2016135707A1 (en) 2015-02-27 2016-09-01 Nestec S.A. Diagnosis of major depressive disorder, mild cognitive impairment, and alzheimer's disease and other neurologic and psychiatric disorders
US11209439B2 (en) 2015-09-24 2021-12-28 Mayo Foundation For Medical Education And Research Identification of immunoglobulin free light chains by mass spectrometry
EP3165922B1 (en) * 2015-11-06 2020-06-17 Promise Proteomics A method for quantifying therapeutic antibodies
EP3430172A4 (en) 2016-03-17 2019-08-21 Cedars-Sinai Medical Center METHOD FOR DIAGNOSIS OF INFLAMMATORY ENDURANCE THROUGH RNASET2
JP2019522199A (ja) 2016-07-08 2019-08-08 アトノミックス アクティーゼルスカブ 試料中の治療用モノクローナル抗体及びそれらの対応する抗薬物抗体の量を確定するためのユニバーサルアッセイ
CN109564223A (zh) * 2016-09-06 2019-04-02 富士瑞必欧株式会社 肿瘤标记物的测定方法及测定试剂
CN109863395B (zh) 2016-09-07 2023-05-23 梅约医学教育与研究基金会 分子量法鉴定和监测裂解免疫球蛋白
EP3681528A4 (en) 2017-09-13 2021-07-21 Mayo Foundation for Medical Education and Research IDENTIFICATION AND MONITORING OF THE APOPTOSIS INHIBITOR OF MACROPHAGES
EP3830579A1 (en) * 2018-08-03 2021-06-09 Bristol-Myers Squibb Company Methods for detecting anti-drug antibodies
JP2020115139A (ja) * 2020-03-11 2020-07-30 国立大学法人千葉大学 血管炎の検査方法
CN112362649A (zh) * 2020-11-09 2021-02-12 长春金赛药业有限责任公司 一种rhGH中和抗体的检测方法
KR102562006B1 (ko) 2020-11-09 2023-08-02 바디텍메드(주) 항tnf-알파 약물 모니터링을 위한 신속 검출 키트
KR102568430B1 (ko) * 2020-11-16 2023-08-24 바디텍메드(주) 항 약물 항체의 신속 검출 방법
CN114236139A (zh) * 2021-12-30 2022-03-25 苏州和锐生物科技有限公司 一种TNF-α生物制剂的抗体检测试剂盒、制备方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4459359A (en) * 1981-11-19 1984-07-10 New York Blood Center, Inc. Sensitive immunoassays of antigens or antibodies sequestered within immune complexes
FR2590674B1 (fr) * 1985-11-25 1989-03-03 Inst Nat Sante Rech Med Nouveaux reactifs de diagnostic
DE3631229A1 (de) 1986-09-13 1988-03-24 Basf Ag Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung
US5094740A (en) * 1990-02-16 1992-03-10 Glycomed, Inc. Two-dimensional electrophoretic separation of carbohydrates
GB9028123D0 (en) * 1990-12-28 1991-02-13 Erba Carlo Spa Monoclonal antibodies against human tumor necrosis factor alpha
US6074835A (en) 1996-04-12 2000-06-13 Regents Of The Univ. Of California Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone H1
US6033864A (en) 1996-04-12 2000-03-07 The Regents Of The University Of California Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
US6406862B1 (en) 1998-10-06 2002-06-18 The United States Of America As Represented By The Secretary Of The Army Dip-stick assay for C-reactive protein
CA2364026C (en) * 1999-03-02 2012-08-21 Centocor, Inc. Anti-tnf.alpha. antibodies in therapy of asthma
US6309643B1 (en) 1999-04-30 2001-10-30 The Regents Of The University Of California IBD-associated microbial antigens and methods of using same
FR2802536B1 (fr) 1999-11-23 2003-06-13 Chru Lille Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections
FR2806739B1 (fr) 2000-03-27 2005-02-18 Fond Jean Dausset Ceph Genes impliques dans les maladies inflammatoires de l'intestin et leur utilisation
US6838250B2 (en) 2000-03-31 2005-01-04 Ortho-Clinical Diagnostics, Inc. Immunoassay for C-reactive protein
US7138237B1 (en) 2000-05-19 2006-11-21 Cedars-Sinai Medical Center Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
AU2735002A (en) 2000-10-30 2002-05-15 Univ Michigan Nod2 nucleic acids and proteins
AU4341502A (en) 2000-10-30 2002-06-11 Univ Michigan Nod2 nucleic acids and proteins
US7192724B2 (en) 2000-11-14 2007-03-20 Techlab, Inc. Method for differentiating irritable bowel syndrome from inflammatory bowel disease (IBD) and for monitoring persons with IBD using total endogenous lactoferrin as a marker
AU2002365279B2 (en) 2001-12-17 2009-08-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
US20040053263A1 (en) 2002-08-30 2004-03-18 Abreu Maria T. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease
CA2502976C (en) 2002-10-25 2012-05-22 Techlab, Inc. Inflammatory bowel disease and irritable bowel syndrome ibd-first chek diagnostic panel
US7662569B2 (en) 2003-04-11 2010-02-16 Cedars-Sinai Medical Center Methods of assessing Crohn's disease patient phenotype by I2 serologic response
WO2005041896A2 (en) 2003-11-03 2005-05-12 Duke University Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke
CA2572263A1 (en) * 2004-06-30 2006-01-12 Centocor, Inc. Detection or measurement of antibodies to antigenic proteins in biological tissues or samples
WO2006012472A1 (en) 2004-07-21 2006-02-02 Qualyst, Inc. Apparatus, kits and methods for evaluating binding interactions, for detecting and quantifying binding molecules, and for sample preparation
JP2007147367A (ja) * 2005-11-25 2007-06-14 Sekisui Chem Co Ltd サイトカイン産生能の測定方法
US20110066624A1 (en) 2006-08-01 2011-03-17 Divyank Turakhia system and method of generating related words and word concepts
MX2009003048A (es) 2006-09-21 2009-09-07 Prometheus Lab Inc Disposiciones a base de anticuerpo para detectar transductores de multiple señal en celulas circulantes raras.
KR101553723B1 (ko) 2007-07-13 2015-09-16 네스텍 소시에테아노님 항체­기반 어레이를 사용한 폐 암 치료를 위한 약물 선별법
US20090035216A1 (en) * 2007-08-03 2009-02-05 Biomonitor Aps Method for determining in vivo biopharmaceutical concentration or bioavailability
WO2009022001A1 (en) * 2007-08-16 2009-02-19 Novartis Ag Improvement of drug tolerance in immunogenicity testing
CA2712021A1 (en) * 2008-01-15 2009-07-23 Stichting Sanquin Bloedvoorziening Methods and kits for detecting antibodies against therapeutic antibodies
ES2545760T3 (es) 2008-02-25 2015-09-15 Nestec S.A. Selección de fármacos para terapia del cáncer de mama utilizando matrices de anticuerpos
WO2010042031A1 (en) * 2008-10-07 2010-04-15 Gyros Patent Ab Semi-sequential assay for detection of an analyte in a sample
CA2761777A1 (en) 2009-05-14 2010-11-18 Prometheus Laboratories Inc. Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy
AU2010273319B2 (en) 2009-07-15 2015-01-22 Nestec S.A. Drug selection for gastric cancer therapy using antibody-based arrays
US8408369B2 (en) 2009-09-08 2013-04-02 GM Global Technology Operations LLC Bimetallic brake rotor
CA2777934A1 (en) 2009-10-20 2011-04-28 Prometheus Laboratories Inc. Proximity-mediated assays for detecting oncogenic fusion proteins
RU2571489C2 (ru) * 2009-10-26 2015-12-20 Нестек С.А. Способы выявления препаратов и аутоантител против tnf

Also Published As

Publication number Publication date
NZ614170A (en) 2015-04-24
EP2676137B1 (en) 2014-12-31
IL227853A0 (en) 2013-09-30
ZA201306950B (en) 2015-04-29
CN103502815A (zh) 2014-01-08
AU2012254150A1 (en) 2013-05-02
RU2013142278A (ru) 2015-03-27
BR112013020981A2 (pt) 2016-10-11
IL227853A (en) 2017-07-31
KR20140008397A (ko) 2014-01-21
US20140045276A1 (en) 2014-02-13
JP6063398B2 (ja) 2017-01-18
DK2676137T3 (en) 2015-01-19
JP2014508930A (ja) 2014-04-10
MX2013009570A (es) 2013-09-06
HK1191688A1 (en) 2014-08-01
ES2530175T3 (es) 2015-02-26
CN103502815B (zh) 2015-09-23
AU2012254150B2 (en) 2015-08-13
SG192770A1 (en) 2013-09-30
EP2676137A1 (en) 2013-12-25
CA2827609A1 (en) 2012-11-15
WO2012154253A1 (en) 2012-11-15

Similar Documents

Publication Publication Date Title
MX343327B (es) Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.
MX2012004877A (es) Analisis para la deteccion de farmacos anti-tnf y autoanticuerpos.
MX358517B (es) Métodos para determinar eficacia de fármacos usando proteínas asociadas a cereblon.
BRPI1007321A2 (pt) métodos para medir e/ou quantificar a presença e/ou quantidade de her-3 ou her-3 em um complexo em uma amostra de um paciente, e para determinar se um indivíduo com um câncer é provável de responder ao tratamento com uma terapia alvejada, e, anticorpo.
MX2013000916A (es) Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales.
MX2012009906A (es) Metodos para diagnosticar patogenos de enfermedad infecciosa y su sensibilidad a farmaco.
MX343324B (es) Ensayos para detectar auto anticuerpos neutralizadores de la terapia biologica con tnf alpha.
MX2012010418A (es) Inhibidores syk de imidazopiridinas.
NZ609493A (en) Diagnosis and treatments relating to th2 inhibition
BR112013010015A2 (pt) aparelho e método para detecção não invasiva de doenças que afetam as propriedades estruturais em tecidos biológicos
EP3264090A3 (en) Method for detecting nucleosome adducts
EA201291396A1 (ru) Способ детекции молекулярных взаимодействий
MX2013000675A (es) Metodo para identificar a un paciente con incrementada probabilidad de responder a una terapia anticancer.
MX2015006852A (es) Ensayos para detectar autoanticuerpos neutralizantes para terapia biologica.
WO2014015149A3 (en) Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions
MX358474B (es) Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson.
GB201206977D0 (en) An enzyme detection device
TN2015000161A1 (en) Methylglyoxal as a marker of cancer
WO2015049390A3 (en) Kidney disease biomarker
MX2021009528A (es) Prueba de diagnostico basada en fragmento de rgma.
EP2573192A4 (en) METHOD AND KIT FOR DIAGNOSING DISEASE ASSOCIATED WITH AIM
IN2014DN08398A (es)
SG10201806729VA (en) Novel assay to detect human periostin
WO2014052685A3 (en) Devices and methods for single cell analysis
WO2013101276A3 (en) Diagnosis and detection of disease conditions modulated by activation of the sphingolipid pathway

Legal Events

Date Code Title Description
FG Grant or registration